Difficulty: Medium
Average Score: 94%
Practice
A 29-year-old man with recurrent herpes viral infections of the scrotum and penile shaft presents to his primary care physician because the medication is not working for him. He takes oral acyclovir for these outbreaks. Physical examination reveals active genitourinary herpes disease. What is the most likely explanation for the resistance to this medication?
Correct answer
D
Rationale
In this scenario, the most likely explanation for the resistance to acyclovir in the 29-year-old man with recurrent herpes viral infections is a deficiency in thymidine kinase. Thymidine kinase is an enzyme that is crucial for the activation of acyclovir to its active form. Without sufficient thymidine kinase, the conversion of acyclovir to its active triphosphate form is impaired, leading to reduced effectiveness of the medication.
Option A, deficient DNA synthase, is incorrect because DNA synthase is not directly involved in the activation of acyclovir. Option B, deficient RNA polymerase, and Option C, deficient RNA transferase, are also incorrect as they are not related to the mechanism of action of acyclovir in treating herpes viral infections.
Educationally, understanding the specific mechanism of action of antiviral drugs like acyclovir is crucial for healthcare professionals to make informed decisions regarding treatment options for patients with viral infections. Knowing how resistance can develop, such as through deficiencies in key enzymes like thymidine kinase, can guide clinicians in adjusting treatment strategies for better patient outcomes.
Option A, deficient DNA synthase, is incorrect because DNA synthase is not directly involved in the activation of acyclovir. Option B, deficient RNA polymerase, and Option C, deficient RNA transferase, are also incorrect as they are not related to the mechanism of action of acyclovir in treating herpes viral infections.
Educationally, understanding the specific mechanism of action of antiviral drugs like acyclovir is crucial for healthcare professionals to make informed decisions regarding treatment options for patients with viral infections. Knowing how resistance can develop, such as through deficiencies in key enzymes like thymidine kinase, can guide clinicians in adjusting treatment strategies for better patient outcomes.